To meet the logistics needs of today’s pharmaceutical and healthcare customers, it takes a carrier with a strong pharma background. And Swiss WorldCargo is the right carrier to do so. From providing a wide array of sophisticated, temperature controlled container solutions to leveraging the short tarmac times at Zurich airport, Swiss WorldCargo provides the right infrastructure, facilities and solutions to manage the most diverse requirements. 

Various Swiss WorldCargo products offer solutions that meet the wide-ranging needs of our pharmaceutical and healthcare customers. 

  • SWISS °Celsius Active allows for transportation in a wide range of active temperature-controlled containers in temperature ranges from -20 °C to +20 °C. 
  • SWISS °Celsius Passive offers a choice between four official IATA temperature ranges varying between -60°C and +25°C, alongside standardized processes ensuring the proper environment for storage. 
  • SWISS °Celsius Passive Solutions offers standardized processes to ensure that cargo is stored in a required temperature environment. Uninterrupted cool chain door-to-door is also ensured.
Go to article: Home | The deep dive for new drugsGo to article: In this issueGo to article: NSFGo to article: ContentsGo to article: Hapa Company InsightGo to article: Daiichi JitsugyoGo to article: NewsGo to article: Owen MumfordGo to article: The pharma industry briefingGo to article: Capsugel Company InsightGo to article: Swiss WorldCargoGo to article: In the age of AMR, does a nationalised drug company make sense? The case for and againstGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Underwater forests and the search for natures’ next drug treasure troveGo to article: Barc Lab Go to article: BEAGo to article: Developing drugs for NASH: the race to market Go to article: SmartCAE Company InsightGo to article: SmartCAEGo to article: Zulresso: the world’s first post-partum depression drugGo to article: EcocoolGo to article: Moehs Iberica SLGo to article: Predicting drug flops with AIGo to article: Abiogen PharmaGo to article: LaudaGo to article: Proteomics and the promise of ‘enriching’ clinical trials Go to article: Lubrizol Life SciencesGo to article: SkycellGo to article: EventsGo to article: TemptimeGo to article: Next issueGo to article: Pfanstiehl Company InsightGo to article: Pfanstiehl